Welcome to LookChem.com Sign In|Join Free
  • or
Aristolactam-II is a highly unsaturated alkaloid derived from aristolochic acid. It is found in the callus tissue of Stephania cepharantha and forms a pale yellow amorphous powder with a sharp melting point. Aristolactam-II exhibits blue fluorescence and has characteristic absorption maxima in its ultraviolet spectrum.

55610-00-9

Post Buying Request

55610-00-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55610-00-9 Usage

Uses

Used in Pharmaceutical Industry:
Aristolactam-II is used as a pharmaceutical compound for its potential therapeutic applications. Its chemical and spectroscopic properties make it a promising candidate for the development of new drugs and treatments.
Used in Research and Development:
Aristolactam-II serves as a valuable compound in the field of research and development, particularly in the study of alkaloids, their properties, and potential applications in medicine and pharmacology. Its unique characteristics and relationship to aristolochic acid provide valuable insights for scientists and researchers.
Used in Drug Delivery Systems:
Similar to gallotannin, aristolactam-II could potentially be incorporated into drug delivery systems to enhance its bioavailability and therapeutic outcomes. The development of novel drug delivery systems, such as organic and metallic nanoparticles, could improve the delivery and efficacy of aristolactam-II in various applications.

References

Akasu, Itokawa, Fujita, Tetrahedron Lett., 3609 (1974)

Check Digit Verification of cas no

The CAS Registry Mumber 55610-00-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,6,1 and 0 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 55610-00:
(7*5)+(6*5)+(5*6)+(4*1)+(3*0)+(2*0)+(1*0)=99
99 % 10 = 9
So 55610-00-9 is a valid CAS Registry Number.
InChI:InChI=1/C16H9NO3/c18-16-10-6-12-15(20-7-19-12)14-9-4-2-1-3-8(9)5-11(17-16)13(10)14/h1-6H,7H2,(H,17,18)

55610-00-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name Aristolactam II

1.2 Other means of identification

Product number -
Other names Cepharanone A

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55610-00-9 SDS

55610-00-9Downstream Products

55610-00-9Relevant academic research and scientific papers

DNA adducts of aristolochic acid II: Total synthesis and site-specific mutagenesis studies in mammalian cells

Attaluri, Sivaprasad,Bonala, Radha R.,Yang, In-Young,Lukin, Mark A.,Wen, Yujing,Grollman, Arthur P.,Moriya, Masaaki,Iden, Charles R.,Johnson, Francis

experimental part, p. 339 - 352 (2011/01/03)

Aristolochic acids I and II (AA-I, AA-II) are found in all Aristolochia species. Ingestion of these acids either in the form of herbal remedies or as contaminated wheat flour causes a dose-dependent chronic kidney failure characterized by renal tubulointerstitial fibrosis. In ~50% of these cases, the condition is accompanied by an upper urinary tract malignancy. The disease is now termed aristolochic acid nephropathy (AAN). AA-I is largely responsible for the nephrotoxicity while both AA-I and AA-II are genotoxic. DNA adducts derived from AA-I and AA-II have been isolated from renal tissues of patients suffering from AAN. We describe the total synthesis, de novo, of the dA and dG adducts derived from AA-II, their incorporation site-specifically into DNA oligomers and the splicing of these modified oligomers into a plasmid construct followed by transfection into mouse embryonic fibroblasts. Analysis of the plasmid progeny revealed that both adducts blocked replication but were still partly processed by DNA polymerase(s). Although the majority of coding events involved insertion of correct nucleotides, substantial misincorporation of bases also was noted. The dA adduct is significantly more mutagenic than the dG adduct; both adducts give rise, almost exclusively, to misincorporation of dA, which leads to AL-II-dA→T and AL-II-dG→T transversions. The Author(s) 2009. Published by Oxford University Press.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 55610-00-9